Molecular cloning, heterologous expression and functional characterization of a novel translationally-controlled tumor protein (TCTP) family member from Loxosceles intermedia (brown spider) venom  by Sade, Youssef B. et al.
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a  b  s  t  r  a  c  t
Envenoming  with  brown  spiders  (Loxosceles  genus)  is  common  throughout  the  world.  Cutaneous  symp-
toms following  spider  bite  accidents  include  dermonecrosis,  erythema,  itching  and  pain.  In  some  cases,
accidents  can  cause  hypersensibility  or even  allergic  reactions.  These  responses  could  be associated  with
histaminergic  events,  such  as  an  increase  in  vascular  permeability  and  vasodilatation.  A protein  that  may
be related  to  the  effects  of  spider  venom  was  identiﬁed  from  a  previously  obtained  cDNA  library  of  the
L. intermedia  venom  gland.  The  amino  acid  sequence  of  this  protein  is  homologous  to  proteins  from  theeywords:
rown spider
enom
oxosceles
CTP
istamine-releasing factor
TCTP  (translationally-controlled  tumor  protein)  family,  which  are  extracellular  histamine-releasing  fac-
tors  (HRF)  that  are  associated  with  the  allergic  reactions  to  parasites.  Herein,  we  described  the cloning,
heterologous  expression,  puriﬁcation  and  functional  characterization  of  a  novel  member  of  the TCTP
family  from  the  Loxosceles  intermedia  venom  gland.  This  recombinant  protein,  named  LiRecTCTP,  causes
edema,  enhances  vascular  permeability  and  is  likely  related  to the  inﬂammatory  activity  of  the venom.
Moreover,  LiRecTCTP  presents  an  immunological  relationship  with  mammalian  TCTPs.. Introduction
Brown spiders (Loxosceles genus) are found worldwide, and the
revalence of accidents with these animals has created a pub-
ic health problem, especially in the south-central United States
nd in the southeast region of Brazil. Loxoscelism manifestations
nclude necrotic lesions, gravitational spreading and a massive
nﬂammatory response at the injured site. Lesions are normally
receded by edema, erythema and itching. In a lower percentage
f cases, patients develop hematological dysfunctions and renal
njury, which can evolve to renal failure and even lead to death
Kusma et al., 2008; da Silva et al., 2004). The venom has a complex
olecular composition of several different toxins and is enriched
ith proteins that range from 3 to 40 kDa in molecular mass. The
 GenBank data deposition information for L. intermedia TCTP cloned cDNA is:
enBank ID: JN544929.
∗ Corresponding author at: Department of Cell Biology, Federal University of
araná, Jardim das Américas, 81531-990 Curitiba, Paraná, Brazil.
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mechanisms by which the venom exerts its effects are still under
investigation, although studies have shown that venom compo-
nents act synergistically (da Silva et al., 2004; Appel et al., 2005).
Phospholipases-D, which are major components of venom (also
called dermonecrotic toxins), have been cloned and comprise a
family of toxins present in several Loxosceles species (Chaim et al.,
2006; Appel et al., 2008; da Silveira et al., 2006, 2007; Kalapothakis
et al., 2007).
Histamine has been identiﬁed to be the principal pharmaco-
logical component in the venom of several spiders (Rash and
Hodgson, 2002; Rash et al., 1998). The role of histamine and its
receptors in the development of edema, increased vascular perme-
ability and vasodilatation are considered relevant for loxoscelism
(Rattmann et al., 2008). Histamine can also be released from mast
cells in response to venom components. The presence of histamine
in the envenomation site can cause pain, edema, erythema and
endothelial changes such as increased vascular permeability and
vasodilatation. These effects contribute to the systemic dispersion
Open access under the Elsevier OA license.of the venom components (Mekori and Metcalfe, 2000; Weisel-
Eichler and Libersat, 2004; Paludo et al., 2009).
The TCTP (translationally-controled tumor protein) family rep-
resents a family of proteins that are highly conserved, ubiquitously
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xpressed in eukaryotes and widely expressed in various tissues
nd cell types. The name TCTP is based on the ﬁrst protein of
his family identiﬁed, which originated from a human mammary
arcinoma and on the observation that TCTP is regulated at the
ranslational level and is also called HRF (histamine-releasing fac-
or) (Gachet et al., 1999; Bommer and Thiele, 2004).
Herein, we describe the cloning, expression and puriﬁcation of
 novel, translationally-controlled tumor protein (LiTCTP) family
ember from the cDNA library of the Loxosceles intermedia venom
land. We  named the recombinant molecule LiRecTCTP and evalu-
ted the biological activity of this toxin on vascular permeability.
e also assessed its relationship to mammalian TCTPs from nor-
al  and tumor cells. The results described herein identiﬁed this
iTCTP as a toxin from L. intermedia venom and one of the molecules
esponsible for the histamine-associated symptoms in loxoscelism.
. Materials and methods
.1. Reagents
The whole venom from L. intermedia was obtained by electros-
imulation (15 V) of the cephalotorax of spiders, solubilized in PBS
nd maintained frozen until use (Feitosa et al., 1998). IgGs were
uriﬁed from serum using a mixture of Protein-A and Protein-G
epharose beads (Amersham Biosciences, Piscataway, USA). Ni2+-
TA agarose was purchased from Invitrogen (Carlsbad, USA), and
EAE agarose Bio-Gel was from Bio-Rad (Hercules, USA). F12, RPMI
nd DMEM media were purchased from Cultilab (Campinas, Brazil).
vans Blue dye was purchased from Vetec (São Paulo, Brazil).
.2. cDNA cloning
cDNA for L. intermedia TCTP was isolated from a previously built
enom gland library as described (Gremski et al., 2010; Chaim et al.,
006). Brieﬂy, randomly chosen colonies were transferred to 1.5 mL
icrotubes containing 20 L water, and the suspensions were incu-
ated in a boiling water bath for 10 min. The tubes were centrifuged
or 30 min  at 20,000 × g (4 ◦C), and sequencing reactions were
erformed on both strands of DNA from the supernatants using
 BigDye Terminator v3.1 Cycle Sequencing Kit and an ABI3500
enetic Analyzer (Applied Biosystems, Warrington, UK). The puta-
ive protein product based on the sequenced cDNA was  used to
earch NCBI’s GenBank protein databases (Altschul et al., 1997).
CTP sequences from 13 different organisms were retrieved from
enBank and aligned with the cDNA sequence of the L. interme-
ia TCTP using the software CLUSTAL X2 in the multiple alignment
ode (Thompson et al., 1994). The resulting alignment was  used
o build a phylogenetic tree using the software MEGA 4.0 with the
aximum parsimony method, and the consensus tree was  inferred
rom a 1000 bootstrap replicate test. The tree was  rooted with the
equence from Giardia lamblia (accession number XP 768559) as
t is accepted as the closest organism to an ancestral eukaryote
Hinojosa-Moya et al., 2008).
.3. Recombinant protein expression
The L. intermedia TCTP cDNA was ampliﬁed by PCR using
he following gene-speciﬁc primers: forward primer, 5′-
CGCTCGAGATGATCATTTTTAAGGATTTATTAAC-3′ (the XhoI
estriction site is underlined, and the initiation codon is in bold);
everse primer, 5′-CGGGATCCTTAAACTTTTTCTTCGTCCAAAC-3′
the BamHI restriction site is underlined, and the termination
odon in bold). The ampliﬁed product was digested with XhoI and
amHI enzymes (Fermentas, Hanover, MD,  USA) and cloned into
he pET-14b vector (Novagen, Madison, USA). The correct con-
truction was conﬁrmed by DNA sequencing. The pET-14b cDNAemistry & Cell Biology 44 (2012) 170– 177 171
construct was transformed into one-shot E. coli BL21(DE3) pLysS
competent cells (Invitrogen, Carlsbad, USA) and plated on LB agar
medium containing ampicillin (100 g/mL) and chloramphenicol
(34 g/mL). One colony was then incubated in 10 mL of LB broth
with the same antibiotics at the concentrations described above
and allowed to grow overnight at 37 ◦C. This culture was inoculated
into 1 L of LB broth with antibiotics and grown at 37 ◦C until the
OD at 550 nm reached 0.5. IPTG (isopropyl -d-thiogalactoside)
was  added at a ﬁnal concentration of 0.1 mM,  and induction of the
culture was  performed for 4 h at 23 ◦C.
2.4. Protein puriﬁcation
The sequence cloned into the pET-14b vector was expressed
in the One-Shot Escherichia coli BL21 (DE3) pLysS cells as a fusion
protein with a 6× His-tag at the N-terminus was puriﬁed by afﬁn-
ity chromatography using Ni+2-NTA. E. coli cells were lysed by
thaw–freeze cycles and disrupted by 6 cycles of sonication. The
lysed materials were centrifuged (20,000 × g, 20 min, 4 ◦C), and the
supernatants were incubated with 1 ml Ni2+-NTA beads for 1 h at
4 ◦C. The recombinant protein was  eluted with 10 ml  of elution
buffer (50 mM sodium phosphate pH 8.0, 500 mM NaCl, 250 mM
imidazole), and 1 ml  fractions were collected and analyzed by 12.5%
SDS-PAGE under reducing conditions. Fractions were pooled and
dialyzed against Bis–Tris buffer (Bis–Tris 20 mM,  NaCl 10 mM,  pH
7.2). This protein fraction was then submitted to ion-exchange
chromatography using DEAE agarose (pH 7.2, NaCl 10 mM).  Elution
was  achieved by performing a stepwise gradient with increasing
NaCl concentrations ranging from 0.01 to 1.5 M and the peak of
elution was at 25 mM.
2.5. Animals
Adult Swiss mice (25–30 g) and adult rabbits weighing approxi-
mately 3 kg from the Central Animal House of the Federal University
of Parana were used for in vivo experiments with whole venom and
recombinant toxin. All procedures involving animals were carried
out in accordance with “Brazilian Federal Laws”, following the eth-
ical subcommittee on research animal care agreement number 340
of the Federal University of Parana.
2.6. Antibodies
Polyclonal antibodies to whole venom were previously obtained
as described (Luciano et al., 2004). Likewise, hyperimmune sera
against LiRecTCTP were produced in a rabbit using puriﬁed
LiRecTCTP as an antigen and complete Freund’s adjuvant (Sigma)
for the ﬁrst primary injection at one subcutaneous (SC) point and
two intramuscular (IM) points (20 g of protein divided into three
parts was used as the total antigen). As a booster for the second,
third, and fourth injections, incomplete Freund’s adjuvant (Sigma)
was  similarly injected at 3-week intervals. Twelve days after the
last immunization, blood was collected and the production of spe-
ciﬁc antibodies analyzed by ELISA and Western blotting (Harlow
and Lane, 1988).
2.7. Cell culture
HL-60 and B16-F10 cell lines were obtained from the Ameri-
can Type Tissue Culture Collection (Manassas, USA). Rabbit aorta
endothelial cells, RAEC, were obtained courtesy of Professor Helena
Bonciani Nader (the Federal University of São Paulo – School of
Medicine, São Paulo, Brazil) and were grown in F12 medium supple-
mented with 10% heat-inactivated fetal calf serum (FCS) (Cultilab,
Campinas, Brazil). HL-60 (a promyeloblast cell line) and B16-F10
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Fig. 1. Molecular cloning of LiTCTP: a novel TCTP-related toxin from Loxosceles intermedia. (A) The cDNA and the deduced amino acid sequences of LiTCTP. Arrows show the
annealing position of primers containing restriction sites for endonuclease Xho I (sense primer) and Bam HI (antisense primer). Start and stop codons are in bold. For the
protein  sequence, the TCTP2 signature is highlighted in the black box and the TCTP1 signature is shaded in gray. Glutamine (circled) is not conserved among other organisms,
which  does not allow the ProSite Database to identify this signature in LiTCTP. (B) Multiple alignment of TCTP protein sequences from different species. Sequence alignment
was  performed using the Clustal X2 program and formatted with the BOXSHADE 3.2 program. Fully conserved positions are shaded in black and conservative substitutions
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murine melanoma) cells were maintained in Roswell Park Memo-
ial Institute medium (RPMI-1640, Cultilab) supplemented with 5%
CS (LGC Biotecnologia, Cotia, Brazil). All media were supplemented
ith 40 mg/L gentamycin (Schering-Plough, Kenilworth, USA). The
ell cultures were kept at 37 ◦C in a humidiﬁed atmosphere with
% CO2.
.8. Gel electrophoresis and immunoblotting
The protein concentrations of different samples and LiRecTCTP
ere determined by the Coomassie Blue method (BioRad,
ercules, USA) (Bradford, 1976). For protein analysis, 12.5%
DS-PAGE was performed under reduced conditions, and for
mmunoblotting, proteins were transferred onto nitrocellulose
lters and immunostained with hyperimmune rabbit serum
1:2000), which reacts with LiRecTCTP, or puriﬁed IgG against
hole venom toxins (25 g/mL) (Harlow and Lane, 1988). The
olecular mass markers were acquired from Sigma. Alternatively,eric GTPases. Serines phosphorylated by the Plk enzyme are indicated by arrows.
ding site (MTB) and calcium binding site (CaB) are overlapping and represented in
for TCTP immunodetection in tumor cell extracts, protein extracts
from the HL-60, B16-F10 and RAEC cell lines (30 g) were
run under reducing conditions in a 12.5% SDS-PAGE, trans-
ferred onto nitrocellulose ﬁlters and immunostained using
rabbit pre-immune and hyperimmune serum against LiRecTCTP
(1:5000).
2.9. Paw edema forming activity
Paw edema development was measured at different time inter-
vals (Ribeiro et al., 2007; Gremski et al., 2007). Brieﬂy, groups
of ﬁve mice were injected subcutaneously into the right hind
paw with whole venom (10 g) or LiRecTCTP (20 g dissolved
in 36 L sterile PBS). Control mice were injected with 36 L
PBS or 20 g of recombinant GFP, as a non-related recombi-
nant protein sample (for negative controls). Identically, mice
were injected with increasing concentrations of LiRecTCTP (1,
10, and 20 g dissolved in 36 L sterile PBS). Edema was
f Biochemistry & Cell Biology 44 (2012) 170– 177 173
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Fig. 2. Phylogenetic relationship of LiTCTP to others TCTP family members. A phy-
logenetic tree was generated with the program MEGA 4.0, based on the alignment
made with Clustal X2. Only branches with bootstrap support greater than 50% are
shown. The phylogeny of TCTP proteins reﬂects that of eukaryotes and suggests an
early origin for the protein. LiTCTP is grouped with the TCTP proteins from ticks,
Fig. 3. Expression and puriﬁcation of recombinant LiTCTP (LiRecTCTP). SDS-PAGE
(12.5%) analysis of recombinant TCTP protein expression stained with Coomassie
blue dye. Lanes 1 and 2 show E. coli BL21(DE3)pLysS cells resuspended in SDS-PAGE
gel loading buffer before and after induction for 3.5 h with 0.1 mM IPTG, respec-
tively. Lanes 3 and 4 depict the supernatant from cell lysates obtained by freezingY.B. Sade et al. / The International Journal o
valuated by examining changes in paw thickness using a cal-
brated digital micrometer (Digimess, Sao Paulo, Brazil) at the
ollowing time points: immediately after SC injection (t zero),
nd 5, 10, 20, 30, 60, 120, 240, 360 and 720 min  after injec-
ion.
.10. Effects on vascular permeability
Changes in vascular permeability were assessed by visualizing
xtravasation of Evans Blue dye into the extravascular compart-
ent of the skin (Appel et al., 2008; Udaka et al., 1970). A dilution
f the dye in PBS solution (30 mg/kg of mice) was  injected intra-
enously prior to intradermal injection of samples (10 g) of
iRecTCTP, recombinant GFP (negative control) and crude venom
n = 3 per treatment). PBS was used as a vehicle control. After
0 min, animal were euthanized and dorsal skin was  removed for
isualization of dye leakage.
.11. Statistical analysis
Paw edema measurement results are presented as the
ean ± S.E.M., and the statistical analyses were performed using
nalysis of variance (ANOVA) with the post hoc Tukey test in the
raphPad InStat program version 3.10 for Windows. Results were
onsidered signiﬁcant when p ≤ 0.01.
. Results
.1. Molecular cloning and multiple alignment analysis of TCTP
omologous toxin from the L. intermedia venom gland
By screening clones of a cDNA library of the L. intermedia venom
land, a cDNA homologous with the translationally-controlled
umor protein (TCTP) was obtained. The putative protein product
rom this cDNA was designated LiTCTP (from L. intermedia TCTP).
he complete cDNA sequence of LiTCTP comprises 536 bp and has
n open reading frame that encodes a deduced 172-amino acid
rotein. The calculated molecular mass of the mature protein for
iTCTP was 22.3 kDa and the pI 4.7, as predicted (Protparam tool
rom ExPASy) (Gasteiger et al., 2003) (Fig. 1A). A protein-BLAST
earch using GenBank database revealed that LiTCTP is homologous
o other TCTP proteins from a variety of species. This homology was
nvestigated by a multiple sequence analysis of the putative pro-
ein products of LiTCTP. LiTCTP is most homologous to TCTP from
he ixodid ticks Ixodes scapularis and Amblyomma americanum shar-
ng 69% of sequence identity, as well the tick Dermacentor variabilis
ith respectively 68% of identity (Fig. 1B).
.2. The phylogenetic relationship of LiTCTP with other TCTP
amily members
A phylogenetic tree (Fig. 2) was rooted using the Giardia lamblia
CTP sequence because some authors have suggested that this par-
sitic protist is the closest to a eukaryotic ancestor, as indicated by
ts basal evolutionary position based on analysis of the G. lamblia
enome (Hinojosa-Moya et al., 2008; Morrison et al., 2007). LiTCTP
orms a cluster with TCTPs from ticks that is supported by a high
ootstrap value. The TCTP protein from Dermacentor variabilis has
een described as a functional histamine-releasing factor and is
iologically related to TCTPs from others ticks (Mulenga and Azad,
005; Mulenga et al., 2003). This analysis demonstrates that the
oxosceles intermedia TCTP protein is closely related to histamine-
eleasing factors of ixodid ticks.which were described as histamine-releasing factors.
3.3. Expression and puriﬁcation of LiRecTCTP
Expression experiments were performed in E. coli
BL21(DE3)pLysS cells. The expression of the recombinant toxin
was  optimal when induced for 3.5 h with 0.1 mM of IPTG. Recom-
binant toxins were puriﬁed from the soluble fraction of cell
lysates submitted to 2 steps of chromatography, Ni-NTA agarose
and DEAE-sepharose. Recombinant toxin was eluted from IMAC
Ni-chromatography (immobilized metal–ion afﬁnity chromatog-
raphy) resulting in a fraction enriched in LiRecTCTP. The protein
fraction was  then submitted to ion exchange chromatography
using DEAE agarose (pH 7.2, NaCl 10 mM)  and was eluted with a
high degree of purity using 25 mM of NaCl (Fig. 3, lane 7).and thawing in extraction buffer before and after incubation with Ni2+-NTA beads,
respectively. Lane 5 shows eluted recombinant protein from Ni2+-NTA beads. Lane
6  shows the void from DEAE agarose chromatography and lane 7 shows LiTCTP pro-
tein after elution by DEAE chromatography. Molecular mass markers are shown on
the left.
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Fig. 4. LiTCTP immunoblotting. Proteins were separated by SDS-PAGE (12.5%)
and transferred onto nitrocellulose membranes. Lanes 1 and 2 contain 5 g of L.
intermedia recombinant TCTP exposed to 25 g/mL of rabbit preimmune IgG (1)
and hyperimmune IgG against L. intermedia venom (2). Lanes 3 and 4 contain
40  g of L. intermedia whole venom exposed to preimmune rabbit antisera (3)
and  hyperimmune antisera against recombinant LiTCTP (4), both diluted 1:2000.
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Fig. 5. Paw edema induced by subcutaneous injections of LiRecTCTP. (A) LiRecTCTP
and whole venom elicited mouse paw edemas in a time dependent manner begin-
ning at 5 min after injection (LiRecTCTP-induced maximum edema), and absent after
240  min. Values represent the differences between the edema after injection with
LiRecTCTP, whole venom, GFP (negative control of a puriﬁed recombinant molecule)
or PBS (vehicle control) and initial thickness before injections (basal thickness).
For LiRecTCTP and whole venom, all points up to 120 min  are signiﬁcantly differ-
ent  from vehicle (PBS) values. Edema induced by LiRecTCTP followed the pattern
observed with whole venom injection and regressed to basal thickness 240 min
after the injection for LiRecTCTP and after 360 min  for whole venom. (B) LiRecTCTP
LiRecTCTP and tumor cell line extractslkaline-phosphatase-conjugated goat anti-rabbit IgG was used as a secondary anti-
ody and the reaction was  developed with BCIP/NBT. Molecular mass markers are
hown on the left.
.4. Immunological cross-reactivity of LiRecTCTP and native
enom toxins
Immunoblot analysis (Fig. 4) with polyclonal antibodies pro-
uced against LiRecTCTP in rabbits and with polyclonal antibodies
gainst whole venom toxins from L. intermedia established a
elationship between LiTCTP and brown spider venom. The cross-
mmunoreactivity of antisera for both LiRecTCTP and native LiTCTP
resent in the venom demonstrated that whole venom contains
 protein similar to this recombinant toxin that has the same
mmunogenic epitopes.
.5. Paw edema-forming activity of LiRecTCTP
The edema that develops following an exacerbated inﬂamma-
ion reaction to a brown spider bite is very well described for whole
enom and in response to recombinant phospholipase-D (Ribeiro
t al., 2007; Paludo et al., 2009). However, recombinant isoforms
f phospholipase-D were not able to induce paw edemas of the
ame intensity as observed in whole venom tests. To demonstrate
he edematogenic effect of LiTCTP, we compared the abilities of
hole venom, LiRecTCTP, GFP (green ﬂuorescent recombinant pro-
ein) and PBS to induce subcutaneous edema in vivo in a mouse
odel. GFP was  used as a negative control for puriﬁed recom-
inant molecules and PBS as a control for the vehicle used for
dministration. As shown in Fig. 5, we observed that LiRecTCTP
voked edema in a time- and concentration-dependent manner
especially, between 1 and 10 g, and an edema saturation ten-
ency for 20 g under the experimental conditions used), whereas
FP displayed only residual activity. The subcutaneous injection of
rown spider venom and LiRecTCTP (10 g/paw for whole venom
nd 20 g/paw for LiRecTCTP) triggered an edema formation time
urve (0–720 min) which started increasing around 5 min  (Fig. 5A).
he highest peak of edema formation was observed at 5 min
or LiRecTCTP. The LiRecTCTP edematogenic effect started rapidly
ecreasing until a minimum thickness was reached after 240 min.induced a mouse paw edema in a concentration dependent way. Each point repre-
sents the mean ± S.E.M for ﬁve animals. Signiﬁcantly different from control values:
***p  ≤ 0.001 and **p ≤ 0.01 (Student’s unpaired t-test).
LiRecTCTP affected edema measurements in a dose-dependent
manner (1, 10 and 20 g/paw) (Fig. 5B).
3.6. Effect on vascular permeability
Additionally, we  tested whether LiRecTCTP could cause changes
in vascular permeability by observing vascular leakage of Evans
Blue dye in mice injected with whole venom and LiRecTCTP. Recom-
binant GFP and PBS were used as a negative and vehicle control,
respectively. Injection of crude venom caused an intense dye leak-
age localized around the injection point. Injection of LiRecTCTP also
resulted in vascular permeability, but mice presented a more dif-
fuse pattern of dye leakage with several extravasation points near
the injection site. Recombinant GFP and PBS injected mice showed
no alterations in vascular permeability (Fig. 6).
3.7. Immunological cross-reactivity of polyclonal serum againstTo further evaluate the presence of LiTCTP homologous proteins
in different cell types and strengthen the idea of a conserved family
Y.B. Sade et al. / The International Journal of Biochemistry & Cell Biology 44 (2012) 170– 177 175
Fig. 6. Effect of LiRecTCTP on vascular permeability of skin vessels. Mice were injected intradermally with 10 g of LiRecTCTP, crude venom and recombinant GFP (negative
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sontrol). PBS was  used as a vehicle control. Dye leakage was induced by crude ve
reated  with GFP and PBS. While venom evoked a localized and intense dye extrav
esponse. Scale bar points 1 cm.
f molecules in different organisms, we performed western blot-
ing analysis using cell extracts and the antibody raised against
iRecTCTP. This evaluation included cell extracts from tumor cell
ines, such as the murine highly metastasizing melanoma cell line
16-F10 and the human promyelocytic leukemia cell line HL-60,
nd extracts from the rabbit aortic endothelial cell line RAEC. As
epicted in Fig. 7, lanes 2, 4, and 6 containing B16-F10, HL-60 and
AEC cell extracts, respectively, reacted positively to hyperimmune
ig. 7. LiRecTCTP-speciﬁc antibodies recognize proteins in extracts from tumor and
on-tumor cell lines. B16–F10 (1–2), HL-60 (3–4) and RAEC (5–6) cell extracts
30 g) were separated by SDS-PAGE (12.5%) and transferred onto nitrocellulose
embranes. LiTCTP related proteins were identiﬁed using antisera hyperimmune
2,  4, and 6) and preimmune against LiRecTCTP (1, 3, and 5), both diluted 1:5000.
lkaline-phosphatase conjugated goat anti-rabbit IgG was used as a secondary anti-
ody, and the reaction was  developed with BCIP/NBT. Molecular mass markers are
hown on the left.nd LiRecTCTP compared to minimal changes in vascular permeability in animals
n, LiRecTCTP induced several points of vessel permeability suggesting a systemic
serum against LiRecTCTP at different mass ranges for the proteins
in nitrocellulose membranes. As a negative control, preimmune
serum did not reveal any unspeciﬁc reactions when exposed to the
same cell extracts (lanes 1, 3, and 5).
4. Discussion
The TCTP family has attracted much attention for its crucial role
in many cellular functions such as cell division and proliferation and
more recently for its extracellular activity as a histamine-releasing
factor (Bommer and Thiele, 2004; Bheekha-Escura et al., 2000).
In 1990s, an IgE-dependent histamine-releasing factor (HRF) with
sequence homology to TCTP from mice and humans was identiﬁed
and cloned (named p21 and p23, respectively) (MacDonald et al.,
1995). Later, it was  demonstrated that this HRF could promote the
release of histamine from basophiles independent of IgE, and evi-
dences suggested an interaction of this HRF with a unique receptor
on the cell surface (Bheekha-Escura et al., 2000; Kang et al., 2001;
Kim et al., 2009).
Sequence analysis of LiTCTP showed that it contains the signa-
ture region of high sequence homology termed TCTP-2 and also the
TCTP-1 region, which is present but with a non-conserved substi-
tution (glutamine instead of alanine at position 51) (Fig. 1A). This
substitution was suggested to represent a minor change in LiTCTP
structure, which would not affect the C-strand because it occurs
in a ﬂexible region of the molecule and the bigger lateral chain
of glutamine would be admitted with no representative structural
alterations. Within the TCTP-2 signature region of LiTCTP, the cal-
cium and microtubule binding sites are total or partially conserved,
and amino acids related to GTPases interactions are also conserved
(Fig. 1A and B).Among species of the same genus, TCTPs are completely con-
served (Bommer and Thiele, 2004). Multiple sequence alignment
analysis and phylogenic trees support the high degree of iden-
tity of LiTCTP with ixodid tick TCTPs (Figs. 1B and 2). TCTP from
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emacentor variabilis was  characterized as a histamine-releasing
actor and it was shown to biologically related with TCTP pro-
eins from other ticks (Mulenga et al., 2003). The overall identity
f LiTCTP is about 69% with TCTPs from Ixodes scapularis.  Ixodid
icks such as Ixodes scapularis, Dermacentor variabilis and Ambly-
mma americanum are also arthropods from the arachnida class
hat includes Loxosceles intermedia.
The L. intermedia venom gland transcriptome revealed that
CTP is represented in the venom, corresponding to 0.4% of the
ranscripts that encode toxins (Gremski et al., 2010). In the case
f the Loxosceles venom gland, TCTP and other constituents of
hole venom are secreted via holocrine secretion as revealed by
ltrastructural studies of the venom gland (Gremski et al., 2010;
os Santos et al., 2000). The LiTCTP sequence obtained does not
resent a signal peptide for endoplasmic reticulum (ER) translo-
ation (Fig. 1A) suggesting that it is secreted by the exosomal,
on-classical pathway. TCTP secretion from cells proceeds via an
R/Golgi-independent pathway, probably mediated by secreted
esicles called exosomes, which has been suggested as a possi-
le pathway for non-classical protein secretion (Amzallag et al.,
004; Hinojosa-Moya et al., 2008). The TCTP protein has been
ound in biological ﬂuid of asthmatic or parasitized patients, in
aliva from ticks (Hinojosa-Moya et al., 2008; Bommer and Thiele,
004) and in the crude venom of L. intermedia as described herein
Fig. 4).
It has already been shown that L. intermedia venom increases
ascular permeability and induces vascular relaxation in rats
Rattmann et al., 2008), and that these effects occur due to the abil-
ty of venom to degranulate mast cells and release mediators such
s histamine (Paludo et al., 2009). LiTCTP seems to be an earlier
nd quicker component of edema formation compared with the
nﬂammatory response in mouse paws triggered by whole venom
Fig. 5). LiRecTCTP also induced microvascular permeability of skin
essels (Fig. 6). The extravasation pattern was different from that
nduced by crude venom, presenting several leakage points and a
ess localized response. The presence of histamine in the enven-
mation site can cause pain, edema, erythema and endothelial
hanges such as increased vascular permeability and vasodilation,
ll of which contribute to the systemic dispersion of venom com-
onents. Moreover, inﬂammatory responses can be related to both
ast cells and histamine (Paludo et al., 2009; Mekori and Metcalfe,
000; Weisel-Eichler and Libersat, 2004).
The TCTP family possesses a wide range of biological functions
Choi and Hsu, 2007; Bommer and Thiele, 2004). Although TCTPs
re involved in various biological events, the primary physiological
oles for these proteins are still unknown (Sun et al., 2008).
Different studies have identiﬁed several proteins that interact
ith TCTP linking this protein to diverse signaling pathways. Inter-
ctions between TCTP and the following molecules have already
een observed: tubulin (Gachet et al., 1999; Rinnerthaler et al.,
006; Bazile et al., 2009), actin-F (Bazile et al., 2009), the mam-
alian Plk (Yarm, 2002), translation elongation factors eEF1A and
EF1Bbeta (Cans et al., 2003), Mcl-1 (Liu et al., 2005; Li et al., 2001),
SAP6 (Amzallag et al., 2004), Na,K-ATPase (Jung et al., 2004), Bcl-
L (Yang et al., 2005) and Chrf (Burgess et al., 2008). TCTP is involved
n cell cycle regulation and proliferation, malignant transformation
nd in the protection of cells against various stress conditions and
poptosis (Bommer and Thiele, 2004; Chen et al., 2007; Susini et al.,
008). Moreover, the protein has calcium-binding activity and is
apable of stabilizing microtubules, a property that may  be related
o participation of TCTP in cell cycle control, as it TCTP has been
o interact with a checkpoint protein (Chrf) (Burgess et al., 2008).
here is also evidence that TCTP may  be a functional link between
icrotubules and mitochondria that participates in the correct
ocalization of mitochondria during cell division (Rinnerthaler et al.,
006).emistry & Cell Biology 44 (2012) 170– 177
As seen in Fig. 1B, Plk phosphorylation sites were not observed
in LiTCTP, they are only conserved in human, mouse and rat
TCTP proteins, which are evolutionarily close to each other. More-
over, none of the LiTCTP serines are PIk phosphorylation sites
[E–G–(A/E)–(I/G)–(D/T)–(D/E)–S–(L/T)–(I/V)]. As TCTP phosphory-
lation at these sites triggers its disassociation from microtubules
allowing mitosis progression speciﬁcally from metaphase to
anaphase (Bommer and Thiele, 2004), their absence in LiTCTP sug-
gests that for brown spiders, and other organisms, this toxin is
probably not involved in microtubule stabilization during the cell
cycle (Yarm, 2002).
Down-regulation of TCTPs has been implicated in biological
models of tumor reversion (Tuynder et al., 2002, 2004), and the
protein is now the target of various anticancer drugs (Telerman and
Amson, 2009; Efferth, 2005). TCTP protein levels are up-regulated
in cancer cells and in human tumors (Telerman and Amson, 2009;
Efferth, 2005; Slaby et al., 2009; Ma  et al., 2009). TCTP has been pro-
posed as a potential cancer biomarker (van de Sande et al., 2006;
Slaby et al., 2009; Kim et al., 2008) and therapeutic target (Zhu et al.,
2008). Drugs that inhibit TCTP activity resulted in tumor growth
inhibition both in vitro and in vivo (Tuynder et al., 2004). Telerman
and Amson (2009) reported that these drugs disrupt the interac-
tion of TCTP with partner proteins that bind directly to TCTP and
increase its secretion from the cell thereby lowering intracellular
concentrations of TCTP. Antibodies raised against the TCTP from L.
intermedia allowed for the immunodetection of mammalian native
TCTP molecules in the tumor cell lines studied herein (B16-F10
and HL-60, Fig. 7). This raises another promising possibility for this
recombinant toxin in the experimental oncology ﬁeld along with
its potential uses in the immunological and allergenic biomedical
areas. Knowledge about LiTCTP can be used to elucidate not only
different aspects of loxoscelism biology, but can also provide new
insights into the diverse functions of this family of proteins and the
interrelation between them.
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